| 摘要 |
The present invention refers to a crystalline-bioavailable axetyl cephuroxime, which is obtained by treatment of known crystalline or amorphous axetyl cephuroxime with water, or a mixture thereof, at a temperature between +20 and +100 degree C, followed by cooling and separating the crystalline product by known methods.
|
